Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
{{id}} {{{paragraph}}}
Example: tourism industry
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
1 HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese HIGHLIGHTS do not include all the INFORMATION needed to use gemzar safely and effectively. See full PRESCRIBING INFORMATION for (gemcitabine) for injection, for intravenous useInitial Approval: 1996---------------------------RECENT MAJOR CHANGES--------------------------Warning s and Precautions,Hemolytic Uremic Syndrome ( ) 5/2019----------------------------INDICA TIONS AND USAGE--------------------------- gemzar is a nucleoside metabolic inhibitor indicated: in combination with carboplatin, for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.
3 Table 3: Recommended Dose Reductions for Gemzar for Myelosuppression on Day of Treatment in Breast Cancer Treatment Day Absolute granulocyte count
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: